Case Series on Follicular Dendritic Cell Sarcoma – A Rare Entity

Krupashankar. S, Venkatraman Radhakrishn .

Abstract


Follicular dendritic cell sarcomas (FDCS) are rare neoplastic proliferation of spindle to ovoid cells which can resemble normal follicular dendritic cellsmorphologically. FDCS commonly arise from lymph nodes,  but at least        one-third can occur in extranodal sites. Differential diagnosis can be varied as morphologicalfeatures can be similar to other malignancies, but theimmunophenotypic profile is distinct and crucial for diagnosis. Herein, we report a series of 5 cases of FDCS and review theetiopathogenesis, clinical features,  histopathology, immunohistochemistry, differential diagnosis and treatment options for FDCS.

 Keywords: FDCS – Follicular  dendritic   cell   sarcomas,

                           IHC – Immunohisto chemistry

Full Text:

PDF

References


Monda L, Warnke R, Rosai J. A primary lymph node malignancy withfeatures suggestive of dendritic reticulum cell differentiation: a report of 4 cases. Am J Pathol. 1986;122(3):562–572.

Chan J, Pileri S, Delsol G, Fletcher C,Weiss L, Grogg K. Follicular dendriticcell sarcoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classificationof Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press;2008:363–364. World Health Organization Classification of Tumours; Vol 2.

Imal Y, Yamakawa M. Morphology, function and pathology of folliculardendritic cells. Pathol Int. 1996;46(11):807–833.

Saygin C, Uzunaslan D, Ozguroglu M, Senocak M, Tuzuner N. Dendriticcell sarcoma: a pooled analysis including 462 cases with presentation of our caseseries. Crit Rev OncolHematol. 2013;88(2):253–271.

Cheuk W, Chan JK, Shek TW, et al. Inflammatory pseudotumor-likefollicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominalneoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001;25(6):721–731.

Chang K, Weiss L. Other histiocytic and dendritic cell neoplasms. In: JaffeE, Harris N, Vardiman J, Campo E, Arber D, eds. Hematopathology. 1st ed.Philadelphia, PA: Saunders/Elsevier; 2011:829–833.

Sun X, Chang KC, Abruzzo LV, Lai R, Younes A, Jones D. Epidermal growthfactor receptor expression in follicular dendritic cells: a shared feature offollicular dendritic cell sarcoma and Castleman’s disease. Hum Pathol. 2003;34(9):835–840.

Duan GJ, Wu F, Zhu J, et al. Extranodal follicular dendritic cell sarcoma ofthe pharyngeal region: a potential diagnostic pitfall, with literature review. Am JClinPathol. 2010;133(1):49–58.

Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of theentity. SeminDiagnPathol. 1998;15(2):144–154.

Lee IJ, Kim SC, Kim HS, et al. Paraneoplastic pemphigus associated withfollicular dendritic cell sarcoma arising from Castleman’stumor. J Am AcadDermatol. 1999;40(2, pt 2): 294–297.

Meijs M, Mekkes J, van Noesel C, et al. Paraneoplastic pemphigusassociated with follicular dendritic cell sarcoma without Castleman’s disease;treatment with rituximab. Int J Dermatol. 2008;47(6):632–634.

Hsu C, Vega F, Grimes LM, Hunt KK. Follicular dendritic cell sarcoma andassociated myasthenia gravis: true, true, related? J Clin Oncol. 2011;29(13):e369–e371.

Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor:report of 13 additional cases of a distinctive entity. Am J SurgPathol. 1996;20(8):944–955.

Shia J, ChenW, Tang LH, et al. Extranodal follicular dendritic cell sarcoma:clinical, pathologic, and histogenetic characteristics of an underrecognizeddisease entity. Virchows Arch. 2006;449(2):148–158.

Chan JK. Proliferative lesions of follicular dendritic cells: an overview,including a detailed account of follicular dendritic cell sarcoma, a neoplasm withmany faces and uncommon etiologic associations. AdvAnatPathol. 1997;4(6):387–411.

Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cellsarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potentialhigher than currently recognized. Cancer. 1997;79(2):294–313.

Soriano AO, Thompson MA, Admirand JH, et al. Follicular dendritic cellsarcoma: a report of 14 cases and a review of the literature. Am J Hematol. 2007;82(8):725–728.

Grogg KL, Lae ME, Kurtin PJ, Macon WR. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms:report of a novel follicular dendritic cell marker and clinicopathologic data on 12additional follicular dendritic cell tumors and 6 additional interdigitatingdendritic cell tumors. Am J SurgPathol. 2004;28(8):988–998.

Grogg KL, Macon WR, Kurtin PJ, Nascimento AG. A survey of clusterin andfascinexpression in sarcomas and spindle cell neoplasms: strong clusterinimmunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol.2005;18(2):260–266.

Yu H, Gibson JA, Pinkus GS, Hornick JL. Podoplanin (D2-40) is a novelmarker for follicular dendritic cell tumors. Am J ClinPathol. 2007;128(5):776–782.

Go H, Jeon YK, Huh J, et al. Frequent detection of BRAF(V) (600E)mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014;65(2):261–272.

Hornick JL. Soft tissue tumors with prominent inflammatory cells. In:Hornick J, ed. Practical Soft Tissue Pathology: A Diagnostic Approach.Philadelphia, PA: Elsevier Saunders; 2013:257–261.

Krautler NJ, Kana V, Kranich J, et al: Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012; 150:194–206.

Vermi W, Giurisato E,Lonardi S, et al: Ligand-dependent activation of EGFR in follicular dendritic cells sarcomais sustained by local production of cognate ligands. Clin Cancer Res 2013;19: 5027–5038.

Perry AM, Nelson M, Sanger WG, et al: Cytogeneticabnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. In Vivo 2013; 27:211–214.

Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy ofvemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosisharboring the BRAF V600E mutation. Blood. 2013;121(9):1495–1500.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University